(Press-News.org) In the online version of the New England Journal of Medicine, physicians and scientists in Heidelberg, Montreal, and Paris reported on the successful treatment of three young children who were suffering from a severe hemolytic-uremic syndrome (HUS) after an infection with enterohemorrhagic Escherichia coli (EHEC). The infections occurred in 2010. EHEC are the bacteria that cause the current wave of infections that have already claimed ten lives in Germany. The number of suspected and confirmed cases of EHEC has now reached 700.
Eculizumab has been approved in Germany since 2007 and is used to treat a rare blood disease and a rare congenital form of HUS. Two years ago, American physicians reported similar success in children with this form of HUS (NEJM 2009; 360:544-546).
The children suffered from kidney failure and severe neurological disorders. "After several exchanges of blood plasma had no effect, we decided to attempt treatment with Eculizumab," reports Professor Dr. Franz Schaefer, head of the section of Pediatric Nephrology at the Center for Child and Adolescent Medicine at Heidelberg University Hospital.
Within 24 hours of the initial infusion, which was repeated once or twice at intervals of seven days, the clinical condition of the children improved dramatically. Dialysis due to acute kidney failure from HUS could be discontinued. All three children recovered and had no sequelae even six months after the illness.
The researchers decided on using the monoclonal antibody Eculizumab as it interrupts the destructive immune reactions that occur after an infection with EHEC. Eculizumab binds to protein C5, which activates what is called the complement cascade and lead to the destruction of blood cells among other things. With EHEC infections there can also be complement activation, triggered by the Shiga toxin formed by the bacteria.
"We now hope that these results will help the acutely ill patients," said Professor Schaefer. He assumes that even adult patients can profit from therapy with the antibody. "Because of the epidemic in Germany, the publishers of the New England Journal of Medicine decided to accelerate the publishing date of the article, which they have had since February, and they published it immediately after reviewing it," said Schaefer. In addition, the article was sent to all kidney specialists in Germany.
Meanwhile, first treatments of adults and children in German hospitals have started. The German Society of Nephrologists has issued guidelines that the antibody may be given if all others standard treatments like dialysis and plasmapheresis have failed.
INFORMATION:
More information on the Internet:
Article in the New England Journal of Medicine:
http://www.nejm.org/doi/full/10.1056/NEJMc1100859
Contact person:
Prof. Dr. med. Franz Schaefer
Head of the Section of Pediatric Nephrology
at the Center for Child and Adolescent Medicine
at Heidelberg University Hospital
Email: Franz.Schaefer@med.uni-heidelberg.de
http://www.klinikum.uni-heidelberg.de/Sektion-Paediatrische-Nephrologie.825.0.html
Heidelberg University Hospital and Medical Faculty:
Internationally recognized patient care, research, and teaching
Heidelberg University Hospital is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University belongs to the internationally most renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. With about 10,000 employees, training and qualification is an important issue. Every year, around 550,000 patients are treated on an inpatient or outpatient basis in more than 50 clinics and departments with 2,000 beds. Currently, about 3,600 future physicians are studying in Heidelberg; the reform Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany.
Requests by journalists:
Dr. Annette Tuffs
Head of Public Relations and Press Department
University Hospital of Heidelberg and
Medical Faculty of Heidelberg
Im Neuenheimer Feld 672
D-69120 Heidelberg
Germany
phone: +49 6221 / 56 45 36
fax: +49 6221 / 56 45 44
e-mail: annette.tuffs(at)med.uni-heidelberg.de
Antibodies successful in the treatment of the hemolytic-uremic syndrome from EHEC
2011-06-01
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Farin Innovations Launches June Logo Giveaway
2011-06-01
Farin Innovations, Inc. a Miami, FL-based company, is giving away 1 free logo every 2 weeks until June 30, 2011!
If you are interested in a free custom logo for your business, enter before it's too late. It's 100% free!
If you don't have a website, this is a great opportunity for you to get off to the right start. Your logo is the key to the castle, responsible for creating a lasting first impression on your visitors.
Visit the link below, click on the promotion, and proceed to enter to win a free custom logo every 2 weeks until June 30, 2011:
http://www.farininnovations.com/news/press-releases/farin-innovations ...
HbA1C test for glucose monitoring poorly predictive in dialysis patients
2011-06-01
WINSTON-SALEM, N.C. – May 31, 2011 – The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center.
The study appears online in the Clinical Journal of the American Society of Nephrology and is scheduled for the July print issue.
Blood sugar monitoring is a vital part of diabetes management. Patients and physicians rely on the hemoglobin A1c (HbA1c) test to measure an individual's average blood sugar level over the prior three months. ...
Harvard scientists 'see' the early cellular cause of dry eye disease for the first time
2011-06-01
Bethesda, MD—If you are one of the millions of people around the world who struggle with dry eye disease, good news is on the way. A new research discovery published in the Journal of Leukocyte Biology (https://www.jleukbio.org) offers hope for new drugs that treat the cellular cause of the disease rather than its symptoms. That's because the research is the first to identify natural killer (NK) cells, a type of cell that provides innate immunity to the eyes, as promoting the inflammation that plays a critical role in the development of dry eye disease.
"Dry eye disease ...
Long-term study data supports association between childhood ADHD and substance abuse risk
2011-06-01
Analysis of data from two long-term studies of the impact of attention-deficit hyperactivity disorder (ADHD) on the development of psychiatric disorders in young adults confirms that ADHD alone significantly increases the risk of cigarette smoking and substance abuse in both boys and girls. The report from a team of Massachusetts General Hospital (MGH) investigators will appear in the Journal of the American Academy of Child & Adolescent Psychiatry and has been released online.
"Our study, which is one of the largest set of longitudinal studies of this issue to date, ...
Origins of XMRV deciphered, undermining claims for a role in human disease
2011-06-01
Delineation of the origin of the retrovirus known as XMRV from the genomes of laboratory mice indicates that the virus is unlikely to be responsible for either prostate cancer or chronic fatigue syndrome in humans, as has been widely published. The virus arose because of genetic recombination of two mouse viruses. Subsequent infection of lab experiments with XMRV formed the basis of the original association.
Reporting in Science, Vinay Pathak, Ph.D., and his research team from the National Cancer Institute (NCI), part of the National Institutes of Health, in collaboration ...
Extra weight equals better health-related quality of life for blacks, not so for women
2011-06-01
A survey of nearly 4,000 Americans finds that obese women reported significantly worse health than obese men. Blacks who were overweight also reported better health than blacks in the normal or obese weight categories. Respondents were divided into three categories: normal, overweight, or obese, according to their height and weight.
The survey results are published online in the June issue of Springer's journal Quality of Life Research and they come from a study funded by the National Institute on Aging. During the survey, researchers conducted comprehensive telephone ...
Support for local community programs key to climate change response in Arctic
2011-06-01
"When we talk about supporting adaptation to climate change, what we mean is supporting resilience at the community level," says Noorjehan Johnson, Vanier Canada Graduate Scholar in Cultural Anthropology at McGill University. "In the Arctic, much of the resilience is fostered through community institutions, which are playing an increasingly important role in crafting a local-level response to climate change."
Johnson's research has taken her to Kanngiqtugaapik (Clyde River) on Baffin Island, Nunavut. There, she has been finding out how Inuit communities are adapting to ...
Study finds dangerous bacteria on cell phones of hospital patients
2011-06-01
Washington, DC, May 31, 2011 -- Cell phones used by patients and their visitors were twice as likely to contain potentially dangerous bacteria as those of healthcare workers (HCW), according to a study published in the June issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.
A team of researchers from the Department of Medical Microbiology at Inonu University in Malatya, Turkey collected swab samples from three parts of cell phones—the keypad, microphone and ear ...
Medical ethicists working in hospitals need to have standards
2011-06-01
A Queen's University professor is helping standardize practices for healthcare ethicists who consult and give guidance on medical ethics issues to doctors, nurses and patients across the country.
"It's time for healthcare ethicists to have some formal practice guidelines, a governing code of ethics, and uniform education and certification standards," says Cheryl Cline, Director of the Office of Bioethics in the Faculty of Health Sciences and Clinical Ethicist at Kingston General Hospital. "Our job is to provide Canadian patients and their families with high quality ethics ...
Bilingualism no big deal for brain, Kansas researcher finds
2011-06-01
How do people who speak more than one language keep from mixing them up? How do they find the right word in the right language when being fluent in just one language means knowing about 30,000 words?
That's what science has wondered about for decades, offering complicated theories on how the brain processes more than one language and sometimes theorizing that bilingualism degrades cognitive performance.
But University of Kansas psycholinguist Mike Vitevitch thinks that complicated explanations of how the brain processes two or more languages overlook a straightforward ...